News and Events
Latest News
A message from Suzanne McGurn, President and CEO of CADTH
On behalf of the team at CADTH, I’m proud and excited to announce that we have launched the Canadian Journal of Health Technologies, a new open-access journal serving the Canadian and global health technology assessment (HTA) community. You can find it online at canjhealthtechnol.ca and ...
Onasemnogene abeparvovec (Zolgensma) is the first gene therapy used to treat spinal muscular atrophy — a rare progressive and life-threatening condition that often begins in childhood and is caused by a genetic mutation.
Conditions for reimbursement include a price reduction and clinical criteria for initiating treatment.
Today, CADTH recom...
More than 35 evidence reviews are mapped to the prevention, identification, treatment, and management of tuberculosis, and accessible on a digital platform
With the publication of its first condition-level review, CADTH is giving Canadian policy-makers, clinicians, and patients quick access to evidence on a range of health technologies used to ...
View all News
Upcoming Events
The COVID-19 pandemic has definitely affected many different aspects of the Canadian health care system — including the widespread adoption of virtual care. Demand for virtual care is unlikely to diminish over the immediate and long term; therefore, many people are wondering how to best optimize virtual care to ensure its sustainability and its ...
View all Events
